Shareholding disclosure

F. Hoffmann-La Roche AG

Declared position

33.2%

Threshold

Crossed upwards

Timeline

Published

24.03.2004

Transaction

—

Voting rights breakdown

Voting rights acquired33.2%

Voting rights sold0%

Below threshold0%

Notice details

CategoryGroup of shareholders

ExchangeXSWX

Notification ID

T2558D2530

Beneficial owner

F. Hoffmann-La Roche AG

Declared address

F. Hoffmann-La Roche AG, Basel

24.03.2004; Kotierungsprospekt

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

F. Hoffmann-La Roche AG

Basilea Pharmaceutica AG, Allschwil24.03.2004T2558D2530

Disclosure summary

F. Hoffmann-La Roche AG disclosed a holding in Basilea Pharmaceutica AG, Allschwil on the acquisition side, published by SIX Exchange Regulation on 24.03.2004, at 33.2% of voting rights. Notice category: Group of shareholders.

Disclosed position

33.2%

Voting rights acquired

Voting rights acquired33.2%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

F. Hoffmann-La Roche AG disclosed a holding in Basilea Pharmaceutica AG, Allschwil, published on 24.03.2004.

Publication date24.03.2004

Issuing companyBasilea Pharmaceutica AG, Allschwil

Beneficial ownerF. Hoffmann-La Roche AG

Declared addressF. Hoffmann-La Roche AG, Basel

CategoryGroup of shareholders

Voting rights acquired33.2%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDT2558D2530

Commercial register

CHE-105.815.381

Registered

Zefix record

Conditions

24.03.2004; Kotierungsprospekt

Source: SIX Exchange Regulation · Publication date: 24.03.2004

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open